Market Overview

Brean Murray Initiates DexCom at Buy

Brean Murray Carret & Company has initiated coverage on DexCom (NASDAQ: DXCM) with a Buy rating and $12.50 price target.

Posted-In: Brean Murray Carret & CompanyPrice Target Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (DXCM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters